Cosette Pharmaceuticals Acquires Intrarosa from Endoceutics
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Jun 23
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
06 Jun 23
UHG, through its health services unit Optum, has offered to pay $100 in cash per Amedisys share, which…
30 May 23
EffRx Pharmaceuticals develops and commercialise prescription drugs that target musculoskeletal and rare pathologies on European and global markets…
25 May 23
Under the terms of the transaction, Pyxis Oncology expects to issue around 4.4 million shares of its common…
23 May 23
ReNAgade has developed an extensive and complementary platform that integrates its exclusive delivery technologies, such as innovative lipid…
27 Apr 23
Dedicaid has built an AI-based clinical decision support software (CDSS) platform that produces indication-specific CDSS applications from available…
26 Apr 23
The acquisition is expected to expedite the profitability and diversify revenue streams of the ROLVEDON (eflapegrastim-xnst) injection
21 Apr 23
TPG will acquire a majority interest in the community oncology practice management platform, while AmerisourceBergen will buy a…
30 Mar 23
HMC Capital, through its affiliate HealthCo Healthcare & Wellness REIT, will buy a portfolio of 11 private hospitals…
17 Mar 23
The dermatology brands sold by Dr. Reddy's to Eris Lifesciences include Hydroheal, Revilus, Avarta, Aquaderm, and others